See Scientist To Watch Phil Baran describe the artistry of his research in drug discovery.
By Abby Olena | February 1, 2014
Read the full story.
Sign In with your LabX Media Group Passport to leave a comment
Not a member? Register Now!
By Abby Olena
Professor, Chemistry, The Scripps Research Institute. Age: 36
By Jef Akst
More than a third of US drug approvals are based on a single large clinical trial, while others require more in-depth study, according to a new report.
By Kerry Grens
A new alliance between industry, academia, and the government wants to boost the “dismal” success rate of biomarker development.
View the March 2014 contents.
© 1986-2014 The Scientist